TRIAMTERENE

Generic: TRIAMTERENE

Advagen Pharma LtdManufacturer
ORALRoute
TRIAMTERENEActive Substance
2026-10-28Original Approval

TRIAMTERENE is FDA application ANDA220782, sponsored by RUBICON RESEARCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FATIGUE
861 reports
2
DRUG INEFFECTIVE
853 reports
3
NAUSEA
819 reports
4
PAIN
750 reports
5
DIARRHOEA
706 reports
6
DIZZINESS
651 reports
7
DYSPNOEA
628 reports
8
HEADACHE
604 reports
9
CHRONIC KIDNEY DISEASE
551 reports
10
ARTHRALGIA
506 reports